Design Pharmaceuticals
Cambridge, US · Founded 2018 · Delaware corporation
Founders & leadership
OC
Olivier ClytiNamed on SEC filing
JH
John HastewellNamed on SEC filing
DL
Dirk LoeffertNamed on SEC filing
RN
Rob NicolNamed on SEC filing
FD
Fred DomNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$3M disclosed across 1 round · 2022
▶$3MraisedFeb 2022 · 1 investors · BiotechnologyRule 506(b)
▶$3MraisedFeb 2022 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Olivier ClytiDirector
- John HastewellDirector
- Dirk LoeffertExecutive Officer, Director
- Rob NicolExecutive Officer, Director
- Fred DomDirector
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Design Pharmaceuticals raised?
- Design Pharmaceuticals has disclosed $3M raised across 1 round.
- Where is Design Pharmaceuticals headquartered?
- Design Pharmaceuticals is headquartered in Cambridge, US.